Human PD-L1 inhibitor V (TFA)
Human PD-L1 inhibitor V TFA, a human PD-1 protein binding peptide with a Kd value of 3.32 μM. Human PD-L1 inhibitor V TFA inhibit the interaction of hPD-1/hPD-L1[1].
Product Specifications
UNSPSC
12352209
Target
PD-1/PD-L1
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/human-pd-l1-inhibitor-v-tfa.html
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H](CC(O)=O)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](C(C)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCSC)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CCC(N)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(C)C)N.xOC(C(F)(F)F)=O
Molecular Formula
C65H104N20O18S.xC2HF3O2
Molecular Weight
1485.71 (free base)
References & Citations
[1]Qiao Li, et al. Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor. Oncotarget. 2016 Oct 4;7 (40) :64967-64976.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
E0266 1 Unit
Precision Electronic Balance; Precision Balance; Electronic Balance
Sign In for Pricing
View Details 
037669-APC 200 µL
LAMP1, NT (LAMP1, Lysosome-associated membrane glycoprotein 1, CD107 antigen-like family member A, CD107a) (APC) discontinued
Sign In for Pricing
View Details 
221247-01 50 µL
CACNA1G (Voltage-Dependent T-Type Calcium Channel Subunit alpha-1G, Cav3.1c, NBR13, Voltage-Gated Calcium Channel Subunit alpha Cav3.1, CACNA1G, KIAA1123) discontinued
Sign In for Pricing
View Details 221247-02 100 µL
CACNA1G (Voltage-Dependent T-Type Calcium Channel Subunit alpha-1G, Cav3.1c, NBR13, Voltage-Gated Calcium Channel Subunit alpha Cav3.1, CACNA1G, KIAA1123) discontinued
Sign In for Pricing
View Details 